Literature DB >> 16639025

The iron carrier transferrin is upregulated in retinas from patients with age-related macular degeneration.

Itay Chowers1, Robert Wong, Tzvete Dentchev, Ronald H Farkas, Jared Iacovelli, Tushara L Gunatilaka, Nancy E Medeiros, J Brett Presley, Peter A Campochiaro, Christine A Curcio, Joshua L Dunaief, Donald J Zack.   

Abstract

PURPOSE: Iron can cause oxidative stress, and elevated iron levels have been associated with several neurodegenerative diseases including age-related macular degeneration (AMD). Transferrin, an iron transport protein, is expressed at high levels in the retina. The purpose of this study was to assess transferrin involvement in AMD by determining the expression profile of transferrin in retinas with AMD compared with retinas without evidence of disease.
METHODS: Postmortem retinas were obtained from AMD and non-AMD eyes. Expression of transferrin was assessed in a microarray dataset from 33 retinas of unaffected donors and 12 retinas of patients with AMD (six with neovascular AMD and six with non-neovascular AMD). Quantitative real-time RT-PCR (QPCR) was used to confirm the microarray results. Transferrin protein expression was assessed by semiquantitative Western blot analysis and immunohistochemistry.
RESULTS: In comparison to unaffected retinas, mean transferrin mRNA levels, as measured by microarray analysis were elevated 3.5- and 2.1-fold in non-neovascular and neovascular AMD retinas, respectively. Semiquantitative Western blot analysis demonstrated a 2.1-fold increase in transferrin protein in AMD eyes. Immunohistochemistry showed more intense and widespread transferrin label in AMD maculas, particularly in large drusen, Müller cells, and photoreceptors.
CONCLUSIONS: These data demonstrate that transferrin expression is increased in the retinas of patients with AMD relative to those of healthy control patients of comparable age. Along with previous studies that have demonstrated elevated iron levels in AMD retinas, early onset drusen formation in a patient with retinal iron overload resulting from aceruloplasminemia, and retinal degeneration with some features of macular degeneration in the iron-overloaded retinas of ceruloplasmin/hephestin knockout mice, the present study suggests that altered iron homeostasis is associated with AMD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16639025     DOI: 10.1167/iovs.05-1135

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  38 in total

Review 1.  How does the macula protect itself from oxidative stress?

Authors:  James T Handa
Journal:  Mol Aspects Med       Date:  2012-04-05

Review 2.  Iron, the retina and the lens: a focused review.

Authors:  Sixto García-Castiñeiras
Journal:  Exp Eye Res       Date:  2010-03-15       Impact factor: 3.467

Review 3.  Iron metabolism in the eye: a review.

Authors:  M Goralska; J Ferrell; J Harned; M Lall; S Nagar; L N Fleisher; M C McGahan
Journal:  Exp Eye Res       Date:  2008-11-21       Impact factor: 3.467

4.  Expression patterns of iron regulatory proteins after intense light exposure in a cone-dominated retina.

Authors:  Meenakshi Maurya; Tapas C Nag; Pankaj Kumar; Tara Sankar Roy
Journal:  Mol Cell Biochem       Date:  2021-05-13       Impact factor: 3.396

Review 5.  Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging.

Authors:  Alexei Terman; Tino Kurz; Marian Navratil; Edgar A Arriaga; Ulf T Brunk
Journal:  Antioxid Redox Signal       Date:  2010-04       Impact factor: 8.401

Review 6.  Differential Gene Expression in Age-Related Macular Degeneration.

Authors:  Denise J Morgan; Margaret M DeAngelis
Journal:  Cold Spring Harb Perspect Med       Date:  2014-10-23       Impact factor: 6.915

7.  Increased serum proteins in non-exudative AMD retinas.

Authors:  Hannah Schultz; Ying Song; Bailey H Baumann; Rebecca J Kapphahn; Sandra R Montezuma; Deborah A Ferrington; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2019-05-31       Impact factor: 3.467

8.  Lactoferrin Expression in Human and Murine Ocular Tissue.

Authors:  Abrar A Rageh; Deborah A Ferrington; Heidi Roehrich; Ching Yuan; Marcia R Terluk; Elizabeth F Nelson; Sandra R Montezuma
Journal:  Curr Eye Res       Date:  2015-10-02       Impact factor: 2.424

9.  The potential of nanomedicine therapies to treat neovascular disease in the retina.

Authors:  Krysten M Farjo; Jian-Xing Ma
Journal:  J Angiogenes Res       Date:  2010-10-08

Review 10.  Iron homeostasis and toxicity in retinal degeneration.

Authors:  Xining He; Paul Hahn; Jared Iacovelli; Robert Wong; Chih King; Robert Bhisitkul; Mina Massaro-Giordano; Joshua L Dunaief
Journal:  Prog Retin Eye Res       Date:  2007-08-11       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.